ARCTOS MEDICAL
Arctos Medical is a spin-off company from the University of Bern and has developed a revolutionary gene therapy that does not correct rare genetic eye diseases but much more common cases of blindness.
ARCTOS MEDICAL
Founded:
2012-06-06
Address:
Bern, Bern, Switzerland
Country:
Switzerland
Website Url:
http://www.arctosmedical.com
Total Employee:
1+
Status:
Active
Total Funding:
8 M CHF
Technology used in webpage:
U.S. Server Location
Similar Organizations
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Oxford BioMedica
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Current Employees Featured
Founder
Investors List
+ND Capital
+ND Capital investment in Seed Round - Arctos Medical
Novartis Venture Fund
Novartis Venture Fund investment in Seed Round - Arctos Medical
Official Site Inspections
http://www.arctosmedical.com
Unable to get host informations!!!
More informations about "Arctos Medical"
About Arcos - Arcos
Co-founders George Kramer and Chris Meador teamed up in 2009 to develop Arcos, a company driven by the desire to develop and deliver easy-to-use clinical decision support tools for โฆSee details»
Arcos - Crunchbase Company Profile & Funding
Organization. Arcos . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Arcos provides clinical decision support tools to empower health โฆSee details»
Arctos Medical - Crunchbase Company Profile & Funding
Organization. Arctos Medical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Arctos Medical is a developed gene โฆSee details»
Contact Us - Arcos
Support: [email protected]. Contact us for more information! Contact Us Page Form. If you are human, leave this field blank. Reason for Contact (Please check all that apply): * โฆSee details»
Arcos Company Profile - Office Locations, Competitors, Revenue
Arcos is a company that develops and provides clinical decision support tools. It offers Burn Navigator, a tool that guides and monitors IV fluid therapy for adult and pediatric severe burn โฆSee details»
Arcos Company Profile -Sales, Contacts, Competitors โ Buzzfile
Www.arcosmedical.com: Arcos, Inc. is the only company located at 4714 RIVERSTONE BLVD, Missouri City, TX 77459. Map View larger map Directions. ... This organization has been โฆSee details»
Arctos Medical - PitchBook
Arctos Medical General Information Description. Developer of optogenetic therapies designed to treat blind people. The company specializes in developing optogenetic therapies to treat โฆSee details»
Novartis acquires Arctos Medical to expand optogenetics portfolio
Sep 21, 2021 Novartis has acquired Arctos Medical, a Swiss gene therapy start-up developing optogenetic therapies for treating blindness.See details»
Novartis acquires Arctos Medical, expanding optogenetics โฆ
Sep 21, 2021 Acquisition underscores Novartis commitment to using optogenetics-based therapies to restore vision to patients with advanced blindness; Novartis gains one pre-clinical โฆSee details»
ARCTOS Medical is Acquired by Novartis - LinkedIn
Sep 26, 2021 Arctos developed a technology for the treatment of blindness associated with retinal degenerative diseases, based on the work of its scientific founders, Drs. Sonja โฆSee details»
Novartis Acquires Arctos Medical, Expanding Portfolio of
Sep 21, 2021 The acquisition underscores Novartisโ belief in the potential of optogenetics as the basis of successful therapeutics as treatments for patients with inherited retinal diseases that โฆSee details»
Novartis buys gene therapy company Arctos Medical | Nasdaq
ZURICH, Sept 21 (Reuters) - Novartis NOVN.S has bought gene therapy specialist Arctos Medical to boost its efforts finding treatments for patients with severe vision loss, the Swiss โฆSee details»
University of Bern spin-off Arctos Medical acquired by Novartis
Sep 22, 2021 Arctos Medical, a University of Bern spin-off developing optogenetic therapies for treating blindness, was acquired by Novartis. More than two million people globally experience โฆSee details»
Novartis acquires Arctos Medical and its optogenetics based gene ...
Sep 23, 2021 Novartis has acquired Arctos Medical and its pre-clinical optogenetics based AAV gene therapy programs for treating inherited retinal dystrophies such as age related macular โฆSee details»
Novartis buys gene therapy firm Arctos Medical in vision loss โฆ
Sep 21, 2021 Novartis' logo is seen at the cell and gene therapy factory of the Swiss drugmaker in Stein, Switzerland, November 28, 2019. REUTERS/Arnd Wiegmann Purchase Licensing โฆSee details»
Novartis buys gene therapy firm Arctos Medical in vision loss
Sep 21, 2021 Swiss drugmaker Novartis said on Tuesday it has bought gene therapy specialist Arctos Medical for an undisclosed amount, aiming to boost its efforts to find treatments for โฆSee details»
Terms & Conditions - Arcos
TERMS AND CONDITIONS OF WEBSITE USAGE These Terms and Conditions (โTerms of Useโ) set forth below apply to the Arcos, Inc. website arcosmedical.com (โWebsite ...See details»
News & Events - Arcos
September 5, 2024. Arcos exhibiting at the 83rd Annual Meeting of the American Association for the Surgery of Trauma (AAST) on Sep. 11-14. Come see the newest features of Blood โฆSee details»